head and neck carcinoma, squamous cell
Showing 1 - 1 of 1
Triple-Negative Breast Tumors, NSCLC, Head and Neck Carcinoma, Squamous Cell Trial in Worldwide (TAK-659, Nivolumab)
Terminated
- Triple-Negative Breast Neoplasms
- +3 more
-
La Jolla, California
- +21 more
Mar 18, 2020